Last reviewed · How we verify

Moderate to Severe Ulcerative Colitis

80 treatments

Approved treatments

Clinical guidelines

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Moderate to Severe Ulcerative Colitis

What drugs treat Moderate to Severe Ulcerative Colitis?

Tracked treatments include Induction- PF-06480605 450 mg SC Q4W, tumor necrosis factor inhibitors (TNFi), Etrasimod, TNF Inhibitor, Chronic- PF-06480605 50 mg SC Q4W, Velsipity, Induction- PF-06480605 150 mg SC Q4W, Chronic- PF-06480605 150 mg SC Q4W.

What is the treatment for Moderate to Severe Ulcerative Colitis?

Standard treatment for Moderate to Severe Ulcerative Colitis includes Induction- PF-06480605 450 mg SC Q4W, tumor necrosis factor inhibitors (TNFi), Etrasimod, TNF Inhibitor, Chronic- PF-06480605 50 mg SC Q4W. See the treatment landscape page for first-line, second-line and salvage options.

What are the treatment guidelines for Moderate to Severe Ulcerative Colitis?

FDA label publishes guidelines for Moderate to Severe Ulcerative Colitis. 4 guideline references tracked.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing